Reaction #1050100

ord-71c73e3a87404acf82e5763a8c983f19

Solvents

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Otherlodosobenzene (1650 mg, 7.5 mmol, prepared
  2. 2
    workup.ADDITION, 43:60-61 (1963)) was added
  3. 3
    workup.ADDITIONTwo hr after the last addition of the oxidant
  4. 4
    Otherthe solution was evaporated under reduced pressure at 50° C
  5. 5
    workup.DISSOLUTIONThe residue was dissolved in 20 ml of aqueous Na2CO3 solution
  6. 6
    Extractionthe solution was extracted with CH2Cl2 (3×50 ml)
  7. 7
    DryingThe organic layer was dried over Na2CO3
  8. 8
    Otherevaporated under reduced pressure
  9. 9
    OtherThe residue was chromatographed on silica gel
  10. 10
    Washeluting with 1:25 methanol
  11. 11
    OtherSeven oxidation products were obtained from the eluate (see Scheme 2)

Procedure

Aminopyrine hydrochloride was prepared from the free base (Aldrich) by treatment with HCl in ether. lodosobenzene (1650 mg, 7.5 mmol, prepared according to the method of Saltzman et al., Org. Synth., 43:60-61 (1963)) was added with stirring at room temperature in portions every 30 min to a solution of octachloro-octachloro tetrasulfonato Fe(III) porphyrin (6.2 mg 3.9 μmol) in 50 ml of 80:20 H2O:CH3CN containing 678 mg (3.0 mmol) of aminopyrine. Two hr after the last addition of the oxidant, the solution was evaporated under reduced pressure at 50° C. The residue was dissolved in 20 ml of aqueous Na2CO3 solution, and the solution was extracted with CH2Cl2 (3×50 ml). The organic layer was dried over Na2CO3 and evaporated under reduced pressure. The residue was chromatographed on silica gel, eluting with 1:25 methanol:methylene chloride. Seven oxidation products were obtained from the eluate (see Scheme 2): 2,3-dimethyl-4-monomethylamino-1-phenyl-3-pyrazolin5-one (AP-1); 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-2); 4formylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-3); 2,3-dimethyl-4hydroxyamino-1-phenyl-3-pyrazolin-5-one (AP-4); 4-dimethylamino-3hydroxymethyl-2-methyl-1-phenyl-3-pyrazolin-5-one (AP-5); 4-dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one-4-oxide (AP-6); and 4-dimethyl-2,3dimethyl-1-(4-hydroxyphenyl)-3-pyrazolin-5-one (AP-7), 4-formylamino-2-methyl1-phenyl-3-pyrazolin-5-one (AP-8), and 4-formylamino-3-hydroxymethyl-2methyl-1-phenyl-3-pyrazolin-5-one (AP-9).

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05760216uspto-grants-1998_06